Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants.
The DOI matches its Crossref record.
Abstract
Evidence is presented that activation of T cells by allogeneic or modified autologous cells leads to the specific production of two distinct molecular compounds of the PT class. One of these two PT has previously been identified as neopterin. The structure of the other is still under investigation. This conclusion was based on the following findings: a) In vitro both PT were produced by T cells proliferating in response to HLA incompatible allogeneic or to autologous EB-virus-transformed or TNP-haptenized cells. b) In vitro stimulation of T cells with mitogenic lectins or protein antigens, of macrophages with zymosan-complement, of B cells with PWM or EB-virus, and of NK effector cells with tumor targets failed to induce comparable release of these PT. c) In vivo increased amounts of both PT were excreted via the urine during allograft rejection and viral infections. It thus appears that the production of these PT is primarily a feature of activated T cells involved in the control of self integrity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Huber, C., Batchelor, J. R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J., & Wachter, H. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.1.310 · Cited by 1,084
Self-citationJonasch, E., & Haluska, F. G. (2001) · The Oncologist · doi:10.1634/theoncologist.6-1-34 · Cited by 518
Kern, P., Hemmer, C. J., Van Damme, J., Gruss, H.-J., & Dietrich, M. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90563-9 · Cited by 452
Neopterin as Marker for Activation of Cellular Immunity: Immunologic Basis and Clinical Application
(1989) · Advances in Clinical Chemistry · doi:10.1016/s0065-2423(08)60182-1 · Cited by 373
Fuchs, D., Weiss, G., Reibnegger, G., & Wachter, H. (1992) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369209114604 · Cited by 326
Self-citationEl-Deeb, W., Elsohaby, I., Fayez, M., Mkrtchyan, H. V., El-Etriby, D., & ElGioushy, M. (2020) · Acta Tropica · doi:10.1016/j.actatropica.2020.105336 · Cited by 50
Hoyo-Becerra, C., Huebener, A., Trippler, M., Lutterbeck, M., Liu, Z. J., Truebner, K., Bajanowski, T., Gerken, G., Hermann, D. M., & Schlaak, J. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083149 · Cited by 49
Schlaak, J. F., Trippler, M., Hoyo-Becerra, C., Erim, Y., Kis, B., Wang, B., Scherbaum, N., & Gerken, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038668 · Cited by 25
“Interestingly, it has already been shown that different IFN types, including pegylated-IFN forms, are able to induce GCH1 activation with the subsequent increase of BH4 and its precursor neopterin, released from monocytes and macrophages [54,55], which has been widely used as a pharmacodynamic marker in the evaluation…”
Background
Metadata
- Authors
- Huber, C., Fuchs, D., Hausen, A., Margreiter, R., Reibnegger, G., Spielberger, M., & Wachter, H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1983-03-01
- Volume
- 130
- Issue
- 3
- Pages
- 1047-1050
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1549214203
- Cited by
- 152
- References
- 0
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.